 |
Ind-Swift Ltd exports its products to more than 50 countries with the help of Global Business Unit(GBU) which helps in international marketing, which started operation in 2007.
|
|
The GBU Facility is compliant to the GMP specifications of MHRA (UK), TGA (Australia). It has got approval of various drug authorities as: |
» WHO (Geneva). |
» MOH (UAE). |
» TFDA (Tanzania). |
» NDA (Uganda). |
» DACA(Ethiopia) |
» Dar-Al- Dawa DAD (Jordan) |
» ITOCHU (Japan) |
|
We develop and out license our products to UK, Europe, Canada, Australia with leading generic partners such as TEVA, Mylan, Actavis, Stada, Ratiopharm. |
|
We have filed more than 680 dossiers in several countries. |
|
Presently Business Negotiations are under process in Russia, Philippines, Taiwan, Afghanistan, Malaysia, |
|
Costa Rica, Panama, Honduras, Venezuela, Peru, Guyana, Jamaica. Serbia.
|
|
We are also involved in CRAMS( Contract Research & Manufacturing Services)
|
|
Domestic Marketing